Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Tables)

v3.22.2.2
Organization and Nature of Operations (Tables)
 9 Months Ended
Sep. 30, 2022
Organization and Nature of Operations [Abstract]  
Schedule of purchase price of the acquisition
    Allocation  
Tangible Assets Acquired:      
Net working capital   $ (1,186,622 )
Right of use asset     40,093  
Lease liability     (46,970 )
Net Tangible Assets Acquired   $ (1,193,499 )
       
Intangible Assets Acquired:        
Licenses and trademarks        
Brain Scientific Trade Name     133,000  
MemoryMD Trade Name     504,000  
Neurocap Trade Name     188,000  
Neuro EEG Trade Name     11,000  
Patent products        
NeuroCap Developed Technology     10,242,000  
NeuroEEG Developed Technology     35,000  
Net Intangible Assets Acquired   $ 11,113,000  
         
Total Fair Value of Assets Acquired   $ 9,919,501  
       
Consideration:        
Fair value of equity received     7,240,222  
Liabilities assumed     2,987,152  
Loans forgiven     605,311  
Total consideration   $ 10,832,685  
         
Goodwill   $ 913,184